Log in to save to my catalogue

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered...

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4b7976d5c6443a28371914f28df9a39

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network

About this item

Full title

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network

Publisher

Bognor Regis: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.19279-19290

Language

English

Formats

Publication information

Publisher

Bognor Regis: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Metastatic castration‐resistant prostate cancer (mCRPC) is an aggressive form of cancer unresponsive to androgen deprivation therapy (ADT) that spreads quickly to other organs. Despite reduced androgen levels after ADT, mCRPC development and lethality continues to be conducted by the androgen receptor (AR) axis. The maintenance of AR...

Alternative Titles

Full title

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d4b7976d5c6443a28371914f28df9a39

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4b7976d5c6443a28371914f28df9a39

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.6481

How to access this item